A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2100462
Non-depleting CD4 monoclonal antibodies may be used in treatment of insulin- dependent diabetes mellitus.
Cooke Anne
Waldmann Herman
Mccarthy Tetrault Llp
University College London
LandOfFree
Non-depleting cd4-specific monoclonal antibodies for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-depleting cd4-specific monoclonal antibodies for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-depleting cd4-specific monoclonal antibodies for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1642592